Survival After Intervention for Single-Ventricle Heart Disease Over 15 Years at a Single Institution

Alexander Zhu1, James M Meza1, Neel K Prabhu1

  • 1Department of Surgery, Duke Children's Pediatric & Congenital Heart Center, Duke Children's Hospital, Durham, North Carolina.

Insights

Survival in single-ventricle (SV) heart disease varies by anatomy and procedure. Less invasive interventions and achieving a two-ventricle circulation improve outcomes for children with SV heart disease.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Surgical Outcomes

Background:

  • Single-ventricle (SV) heart disease encompasses diverse malformations with similar hemodynamics.
  • Outcome disparities suggest influence of morphology, patient factors, and interventions.

Purpose of the Study:

  • To comprehensively review survival rates after interventions for SV heart disease.
  • To identify factors influencing survival in pediatric SV heart disease patients.

Main Methods:

  • Defined SV heart disease and stratified patients into diagnostic and procedural groups.
  • Analyzed 10-year survival data for 381 patients undergoing intervention between 2005-2020.

Main Results:

  • Ten-year survival ranged from 55% (hypoplastic left heart syndrome) to 89% (double inlet left ventricle).
  • Less invasive procedures (ductal stent, pulmonary artery banding) showed superior survival compared to Norwood procedure.
  • Achieving biventricular circulation (87%) improved survival over remaining SV physiology (63%).
  • Risk factors for mortality included chromosomal abnormalities, low weight, hybrid Norwood, non-left ventricular dominance, and earlier operations.

Conclusions:

  • Survival in SV heart disease is linked to cardiac anatomy, patient characteristics, and procedural complexity.
  • Left ventricular dominance, recent interventions, and biventricular circulation attainment correlate with better survival.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
50
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
43
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
44
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
31
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
62